Physician Assistant · Los Angeles, CA
NPI
1164725677
Since 2010
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
10833 Le Conte Ave
Los Angeles, CA, 90095
Phone (310) 794-7700
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,601
10,299 services
Medicare patients, 2024
40
Average age 73
Drug cost, 2024
$160K
1,044 prescriptions
Company payments, 2025
$14K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keith V Regets was code J1071 (injection, testosterone cypionate, 1 mg), 10,190 times for 14 patients. In total Keith V Regets billed 10,299 services in 10 codes, and Medicare paid $3,601.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 10,190 | 14 | $0.02 | $169 |
| 96372 Injection Administration | Office | 69 | 13 | $9.74 | $672 |
| 99214 Office E&M - Established | Office | 14 | 14 | $65.20 | $913 |
By year: 2022 $8,922 for 18,418 services; 2023 $1,829 for 13,830 services; 2024 $3,601 for 10,299 services.
Medicare prescription drug claims, 2024
In 2024, the drug Keith V Regets prescribed most often to Medicare patients was Testosterone Cypionate, with 330 prescriptions and refills. In total Keith V Regets wrote 1,044 Medicare prescriptions that cost $160K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Testosterone Cypionate Generic | 330 | 444 | 102 | $16K |
| Testosterone Generic | 179 | 252 | 68 | $29K |
| Xyosted Testosterone Enanthate | 131 | 135 | 24 | $82K |
| Tamsulosin Hcl Generic | 93 | 273 | 46 | $1,879 |
| Anastrozole Generic | 54 | 140 | 27 | $306 |
| Cabergoline Generic | 43 | 84 | 14 | $3,058 |
| Finasteride Generic | 38 | 113 | 18 | $641 |
| Tadalafil Generic | 22 | 36 | Under 11 | $614 |
| Solifenacin Succinate Generic | 16 | 43 | Under 11 | $360 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 14 | 28 | Under 11 | $140 |
| Doxazosin Mesylate Generic | 12 | 20 | Under 11 | $309 |
| Dutasteride Generic | 11 | 32 | Under 11 | $267 |
Brand drugs: - claims; generic drugs: 876 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Keith V Regets $14K ($14K in general payments such as food, travel and fees) from 10 companies. The largest payer was Boston Scientific Corporation with $4,472.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 20 | $4,472 |
| Verity Pharmaceuticals Inc. | 11 | $3,847 |
| Endo USA, Inc. | 12 | $3,198 |
| Antares Pharma, Inc. | 5 | $1,925 |
| Procept Biorobotics Corporation PRCT | 2 | $157 |
| Urogen Pharma, Inc. URGN | 3 | $116 |
| Teleflex LLC TFX | 1 | $37.1 |
| C. R. Bard, Inc. & Subsidiaries BDX | 1 | $24.16 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $23.66 |
| ABC Home Medical Supply, Inc. | 1 | $18.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.